An International Observational Study of Adults With Acute Infection (NCT07069400)
🩺 Plain-English Summary (8th-Grade Level)
Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.
Who can join: Review the eligibility criteria below.
Location: Banner University Medical Center Tucson — Tucson, Arizona
Age range: 18 Years
🧪 Interventions in This Study
- No intervention (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (56 Sites)
Showing the first 25 of 56 sites.
- Banner University Medical Center Tucson — Tucson, Arizona
- Stanford University Hospital & Clinics (Site 203-003) — Palo Alto, California
- UCSF Medical Center (Site 203-001) — San Francisco, California
- Orlando VA Medical Center (074-032) — Orlando, Florida
- University of Illinois at Chicago (Site 008-012) — Chicago, Illinois
- Lutheran Medical Group — Fort Wayne, Indiana
- University of Kansas Medical Center (Site 080-044) — Kansas City, Kansas
- University of Minnesota — Minneapolis, Minnesota
- Mayo Clinic (Site 054-001) — Rochester, Minnesota
- University of Nebraska Medical Center (Site 080-045) — Omaha, Nebraska
- New York University Langone Health (301-013) — New York, New York
- Mount Sinai Medical Center (Site 301-012) — New York, New York
- Duke University (301-006) — Durham, North Carolina
- Wake Forest Baptist Health (210-001) — Winston-Salem, North Carolina
- Cleveland Clinic Foundation (Site 207-001) — Cleveland, Ohio
- Vanderbilt University Medical Center (Site 212-001) — Nashville, Tennessee
- UT Southwestern Medical Center (084-001) — Dallas, Texas
- MEDVAMC (Site 074-006) — Houston, Texas
- Intermountain Medical Center (Site 211-001) — Murray, Utah
- West Virginia University Medicine (301-023) — Morgantown, West Virginia
- Instituto Medico Platense (611-025) — La Plata, Buenos Aires
- Hospital General de Agudos JM Ramos Mejia (Site 611-001) — Buenos Aires,
- Royal Prince Alfred Hospital (612-056) — Camperdown, New South Wales
- St. Vincent's Hospital (612-002) — Sydney, New South Wales
- Westmead Hospital (Site 612-058) — Westmead, New South Wales
📞 Contact the Study Coordinator
Phone: (612) 624-9644
Email: webe0376@umn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Infectious Disease
- AnovaOS Network Powered Patient Registry — Arlington Heights, Illinois
- Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection — Chicago, Illinois
Explore by condition: All Infectious Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.